Safety of IL-17 and IL-23 inhibitors as treatment for immune mediated inflammatory diseases at conception and during pregnancy: an ENTIS study. (SAFE-PPREG)

26/03/2026
26/03/2026
EU PAS number:
EUPAS1000000960
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol - IL17 23 pregnancy - v 02022026.pdf

English (562.15 KB - PDF) View document
Study results
Study report
Other information